O‘zbekiston кardiologiyasi Ҷилди 1 № 2 (2024) · Саҳифаҳои 122-131
Individualized approach to high-risk therapy: comparative assessment of fixed and separate combinations of antihypertensive and hypolipidemic drugs
Файзуллаева, Ш, Хамидуллаева, Г, Абдуллаева, Г, Юсупова, Х, Бекметова, С, Юлдашева, А, Fayzullayeva, Shakhlo, Khamidullayeva, Gulnoza, Abdullayeva, Guzal, Yusupova, Hafiza, Bekmetova, Sevara, Yuldasheva, Alina, Fayzullayeva, Shaxlo, Xamidullayeva, Gulnoza, Abdullayeva, Guzal, Yusupova, Hafiza, Bekmetova, Sevara, Yuldasheva, Alina
Аннотатсия
Background. Uncontrolled arterial hypertension in patients at high and very high cardiovascular risk remains a significant issue in modern medicine. Optimizing antihypertensive therapy using fixed or separate combinations of drugs represents a promising approach to improving blood pressure control and reducing the risk of cardiovascular complications. Materials and methods. The study included 40 patients (men and women) with grade I–III hypertension according to the ESC/ESH classification (2018). The mean age was 51.52 ± 9.43 years, and the average disease duration was 8.52 ± 6.64 years. Patients were divided into two groups: one received a fixed combination (lisinopril/amlodipine/rosuvastatin), and the other received a separate combination (perindopril/amlodipine and rosuvastatin). Treatment lasted for 3 months. Effectiveness was assessed using 24-hour blood pressure monitoring, applanation tonometry, echocardiography, ultrasound examination of brachiocephalic arteries, and laboratory analyses (lipid profile, glucose level, uric acid, and creatinine). Results. Both therapy regimens demonstrated high antihypertensive, organoprotective, and hypolipidemic effectiveness. However, patients receiving the fixed combination showed a more significant reduction in systolic and diastolic blood pressure, improved lipid profile, and decreased nighttime blood pressure variability. No adverse effects on metabolic profiles were observed. Conclusion. The fixed combination of drugs demonstrated superiority over the separate combination regimen, providing better blood pressure control and lipid profile improvement. These findings highlight the importance of selecting optimal therapy regimens for high cardiovascular risk patients and confirm the efficacy of fixed combinations in this patient group.
arterial hypertensionblood Pressure ControlACE inhibitorscalcium channel blockersstatinscardiovascular risk managementaртериальная гипертензияконтроль артериального давленияингибиторы АПФблокаторы кальциевых каналов
Манбаи метамаълумот: бойгонии OAI-PMH-и маҷалла · Sindex матни пурраро нигоҳ намедорад, ба манбаъ пайванд медиҳад.